REGULATION OF MEMBRANE FUSION
REGULATION OF MEMBRANE FUSION
批准号:
7958272
负责人:
RICHARD W COMPANS
金额:
$5.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30
关键词:
AffectAmino Acid SequenceCell fusionCell physiologyChimeric ProteinsComputer Retrieval of Information on Scientific Projects DatabaseCytoplasmic TailExhibitsExtracellular DomainFamilyFundingGlycoproteinsGrantInfluenza HemagglutininInstitutionInvestigationLung diseasesMembrane FusionModelingMurine leukemia virusMusNucleotidesOncogenicParamyxovirusPrimatesProteinsR peptideRegulationReportingResearchResearch PersonnelResourcesRetroviridaeRoleSourceTestingUnited States National Institutes of HealthViralVirusVirus-Induced Membrane Fusionenv Gene Productsinhibitor/antagonistmutantparainfluenza virus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The long-term objective of this project has been to develop a detailed understanding of the process of cell entry of enveloped viruses, and mechanism of virus-induced cell fusion. We continued our studies with murine leukemia virus, a model oncogenic retrovirus, and parainfluenza virus, an important cause of respiratory disease. For the current reporting period the project focused on findings that the cytoplasmic domains of viral glycoproteins of two distinct virus families are able to regulate fusion activity. We continued our investigation of the role of cytoplasmic domains and structural
features, which are important for their ability to modulate fusion activity. We determined the mechanism by which specific amino acid sequences in cytoplasmic tails of murine retrovirus Env proteins serve as potent inhibitors of virus-induced membrane fusion. To further define role of R peptide in regulation of fusion activity, we investigated its effects on stabilization of the oligomeric state of the Env protein.
We have also continued to test the hypothesis that R peptide increases activation energy required for triggering conversion of Env from a metastable to a fusion-competent state. To investigate whether R peptide can affect a conformational change in external domain, we used influenza HA chimeric proteins having wild type or mutant MuLV Env cytoplasmic domains. We also determined if differences in interactions with cellular factors are observed with Env proteins having cytoplasmic domains that differentially affect fusion activity. We also have begun to investigate a newly
characterized paramyxovirus, SER virus, which is closely related to SV5 in nucleotide and amino acid sequences.
We have found that F protein of SER virus exhibits no cell fusion activity and that this is the result of an extended F cytoplasmic domain. We continued to define sequences in the SER cytoplasmic domain which modulate fusion activity, and possible mechanism involved in suppression of fusion activity by F cytoplasmic domain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Skin Vaccination Against Influenza in the Young And Aged
-
批准号:9210049
-
项目类别:
-
资助金额:$67.49万
-
财政年份:2015
-
负责人:RICHARD W COMPANS
-
依托单位:
Skin Vaccination Against Influenza in the Young And Aged
-
批准号:8886505
-
项目类别:
-
资助金额:$70.29万
-
财政年份:2015
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8257884
-
项目类别:
-
资助金额:$99.15万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8650780
-
项目类别:
-
资助金额:$102.71万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8463750
-
项目类别:
-
资助金额:$94.84万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC)
-
批准号:8357468
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8076663
-
项目类别:
-
资助金额:$96.61万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8837557
-
项目类别:
-
资助金额:$120.24万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
VLP VACCINES FOR HIV PREVENTION
-
批准号:8357486
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8278665
-
项目类别:
-
资助金额:$49.29万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC)
-
批准号:8172422
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8471051
-
项目类别:
-
资助金额:$46.33万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8075656
-
项目类别:
-
资助金额:$49.22万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
REGULATION OF MEMBRANE FUSION
-
批准号:8172444
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:7988855
-
项目类别:
-
资助金额:$49.72万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC
-
批准号:7958248
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2009
-
负责人:RICHARD W COMPANS
-
依托单位:
Novel VLP vaccines for pandemic influenza virus
-
批准号:7914758
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2009
-
负责人:RICHARD W COMPANS
-
依托单位:
Novel Vaccine Strategies Against Ebola Virus
-
批准号:7372039
-
项目类别:
-
资助金额:$38.35万
-
财政年份:2008
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC
-
批准号:7715853
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2008
-
负责人:RICHARD W COMPANS
-
依托单位:
Novel Vaccine Strategies Against Ebola Virus
-
批准号:7617085
-
项目类别:
-
资助金额:$38.67万
-
财政年份:2008
-
负责人:RICHARD W COMPANS
-
依托单位:
海外基金